Lapa P - Search Results

1

Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial.

Iagaru A, Mittra E, Mosci C, Dick DW, Sathekge M, Prakash V, Iyer V, Lapa P, Isidoro J, de Lima JM, Gambhir SS. Iagaru A, et al. Among authors: lapa p. J Nucl Med. 2013 Feb;54(2):176-83. doi: 10.2967/jnumed.112.108803. Epub 2012 Dec 14. J Nucl Med. 2013. PMID: 23243299 Free article. Clinical Trial.

2

Combined 18F-fluoride and 18F-FDG PET/CT: a response based on actual data from prospective studies.

Iagaru A, Mosci C, Dick DW, Sathekge M, Lapa P, de Lima JM, Gambhir SS. Iagaru A, et al. Among authors: lapa p. Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1922-4. doi: 10.1007/s00259-013-2556-y. Epub 2013 Sep 21. Eur J Nucl Med Mol Imaging. 2013. PMID: 24057457 No abstract available.

3

Assessment of skeletal tumour burden on 18F-NaF PET/CT using a new quantitative method.

Lapa P, Marques M, Costa G, Iagaru A, Pedroso de Lima J. Lapa P, et al. Nucl Med Commun. 2017 Apr;38(4):325-332. doi: 10.1097/MNM.0000000000000654. Nucl Med Commun. 2017. PMID: 28230714

4

Metabolic tumor burden quantified on [¹⁸F]FDG PET/CT improves TNM staging of lung cancer patients.

Lapa P, Oliveiros B, Marques M, Isidoro J, Alves FC, Costa JMN, Costa G, de Lima JP. Lapa P, et al. Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2169-2178. doi: 10.1007/s00259-017-3789-y. Epub 2017 Aug 7. Eur J Nucl Med Mol Imaging. 2017. PMID: 28785842

5

¹⁸F-FDG PET/CT in lung cancer. The added value of quantification.

Lapa P, Marques M, Isidoro J, Barata F, Costa G, de Lima JP. Lapa P, et al. Rev Esp Med Nucl Imagen Mol. 2017 Nov-Dec;36(6):342-349. doi: 10.1016/j.remn.2017.04.001. Epub 2017 May 27. Rev Esp Med Nucl Imagen Mol. 2017. PMID: 28566260 English, Spanish.

6

Superiority of 18F-NaF PET/CT for the detection of bone metastases.

Lapa P, Pedroso de Lima J. Lapa P, et al. Nucl Med Commun. 2018 Apr;39(4):344-345. doi: 10.1097/MNM.0000000000000806. Nucl Med Commun. 2018. PMID: 29533347 No abstract available.

7

[A new method for quantification of hepatobiliary scintigraphy using 99mTc-mebrofenin. A comparative study].

Lima JM, Lima JJ, Isidoro J, Lapa P. Lima JM, et al. Among authors: lapa p. Rev Esp Med Nucl. 2003 Jul-Aug;22(4):244-9. doi: 10.1016/s0212-6982(03)72193-4. Rev Esp Med Nucl. 2003. PMID: 12846949 Free article. Spanish.

8

The value of quantitative analysis in ¹⁸F-NaF PET/CT.

Lapa P, Marques M, Costa G, Lima JP. Lapa P, et al. Rev Esp Med Nucl Imagen Mol. 2017 Mar-Apr;36(2):78-84. doi: 10.1016/j.remn.2016.08.002. Epub 2016 Oct 25. Rev Esp Med Nucl Imagen Mol. 2017. PMID: 27793635 English, Spanish.

9

[PET/CT with 18F-Fluorocholine in Patients with Prostatic Cancer in Biochemical Recurrence].

Lapa P, Silva R, Saraiva T, Figueiredo A, Ferreira R, Costa G, Lima JP. Lapa P, et al. Acta Med Port. 2016 Mar;29(3):182-92. doi: 10.20344/amp.7056. Epub 2016 Mar 31. Acta Med Port. 2016. PMID: 27285094 Free article. Portuguese.

10

[Superiority of 18F-FNa PET/CT for Detecting Bone Metastases in Comparison with Other Diagnostic Imaging Modalities].

Lapa P, Saraiva T, Silva R, Marques M, Costa G, Lima JP. Lapa P, et al. Acta Med Port. 2017 Jan 31;30(1):53-60. doi: 10.20344/amp.7818. Epub 2017 Jan 31. Acta Med Port. 2017. PMID: 28501038 Free article. Portuguese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page